Next Generation of PDGFR Inhibitors Makes Headway in GIST
OncLive,
The exception is gastrointestinal stromal tumors (GIST), in which PDGFR mutations are well-established drivers.
The exception is gastrointestinal stromal tumors (GIST), in which PDGFR mutations are well-established drivers.
Anti–vascular endothelial growth factor (VEGF) therapy is used to treat a wide variety of malignancies, in the front-line…